11.02.2015 Views

barcelona . spain - European Association for the Study of the Liver

barcelona . spain - European Association for the Study of the Liver

barcelona . spain - European Association for the Study of the Liver

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

BARCELONA . SPAIN<br />

132 POSTGRADUATE COURSE SYLLABUS ALCOHOLIC LIVER DISEASE 133<br />

APRIL 18 - 19/2012 THE INTERNATIONAL LIVER CONGRESS TM 2012<br />

(Figure 2) 7 . Moreover, alcohol is also recognized as a c<strong>of</strong>actor in <strong>the</strong> development <strong>of</strong> HCC. An additive<br />

effect has been found between alcohol intake <strong>of</strong> ≥60 g/day and each hepatitis-virus infection. This effect<br />

is more pronounced <strong>for</strong> HCV infection and has been confirmed in different studies. In patients with nonalcoholic<br />

steatohepatitis (NASH), alcohol consumption has been recognized as <strong>the</strong> most significant factor<br />

associated with <strong>the</strong> risk <strong>of</strong> developing HCC.<br />

The proportion <strong>of</strong> HCCs attributable to alcohol consumption varies across <strong>the</strong> world, from 45% in Europe<br />

and <strong>the</strong> USA, to 20% in Japan, and 0% in Africa and Asia 8 . These variations are possibly due to geographical<br />

variations in alcohol consumption (Figure 1) but may be also due to under estimations <strong>of</strong> alcohol-related<br />

HCC in countries where HCV or HBV incidence is still high. In fact, it is surprising to note that Japan and<br />

<strong>the</strong> USA have <strong>the</strong> same per capita alcohol consumption (8 and 9.4, respectively) but only 20% <strong>of</strong> Japanese<br />

HCCs are reported to be related to alcohol compared to 45% in <strong>the</strong> USA 8 . Moreover, South Korea and<br />

France have <strong>the</strong> same per capita alcohol consumption (14.8 and 13.7, respectively), but alcohol-related<br />

HCC is reported as 0% in South Korea compared to 70% in France. However, it is impossible to rule out<br />

a genetic susceptibility to alcohol-related HCC, which could be higher in USA and French populations<br />

compared to Asian. Patterns <strong>of</strong> alcohol consumption are also important because we know that binge<br />

drinking is associated with an elevated incidence <strong>of</strong> sudden death.<br />

GENETIC SUSCEPTIBILITY<br />

As yet, only case-control studies or candidate-gene series have identified genetic-risk factors <strong>for</strong> HCC<br />

in alcoholic patients. These studies have mainly identified polymorphisms in superoxide dismutase<br />

(SOD), liver-iron overload, human hemochromatosis (HFE), glutathione peroxidase, myeloperoxidase,<br />

methylenetetrahydr<strong>of</strong>olate reductase (MTHFR) and, more recently, patatin-like phospholipase A3 (PLPLA3).<br />

Among <strong>the</strong>se risk factors, only <strong>the</strong> first four seem to be specific to alcohol-related HCC; <strong>the</strong> o<strong>the</strong>rs are also<br />

associated with HCV- or HBV-related HCC. Despite <strong>the</strong> incontestable usefulness <strong>of</strong> <strong>the</strong>se studies, we now<br />

need global studies to improve our understanding <strong>of</strong> <strong>the</strong> associations between HCC and alcohol.<br />

No genome-wide association study (GWAS) has been published yet that independently identifies <strong>the</strong><br />

genetic risk factors <strong>for</strong> HCC in alcoholic liver disease. Although GWAS data that evaluate <strong>the</strong> genetic risks<br />

<strong>for</strong> HCC are available, <strong>the</strong>y only provide in<strong>for</strong>mation <strong>for</strong> chronic HBV or HCV infection.<br />

MECHANISMS OF CARCINOGENESIS<br />

In <strong>the</strong> past, alcohol was considered more as a co-carcinogen than a direct carcinogen, but recent studies<br />

have clearly identified ethanol as a liver carcinogen by itself. General mechanisms <strong>of</strong> alcohol carcinogenesis<br />

involve acetaldehyde <strong>for</strong>mation, oxidative-stress induction, <strong>for</strong>mation <strong>of</strong> liver cirrhosis, retinoid depletion,<br />

and DNA-methylation deficiency (reviewed in Seitz et al. 9 and summarized in Figure 3). In <strong>the</strong> liver,<br />

acetaldehyde is quickly metabolized and does not play a major role in HCC.<br />

a.Oxidative stress<br />

Oxidative stress is an important factor in hepatocarcinogenesis, whatever <strong>the</strong> etiology <strong>of</strong> liver disease.<br />

Oxidative stress leads to <strong>the</strong> generation <strong>of</strong> reactive oxygen species (ROS). Ethanol-mediated ROS<br />

<strong>for</strong>mation may be caused by several factors:<br />

• Chronic ethanol consumption causes a 10–20-fold increase in hepatic cytochrome<br />

P450 2E1 (CYP2E1) in animals and humans, resulting in increased ROS production by<br />

<strong>the</strong> CYP2E1-dependent microsomal mono-oxygenase system.<br />

•TNFα production can increase ceramide levels, leading to increased mitochondrial ROS production.<br />

•Hepatic iron overload (increased by chronic alcohol consumption) increases ROS.<br />

ROS induces <strong>the</strong> generation <strong>of</strong> lipid-peroxidation products, such as malondialdehyde and 4-hydroxynonenal<br />

(4-HNE), which can react with DNA bases to <strong>for</strong>m exocyclic DNA adducts that are highly mutagenic.<br />

b. Cirrhosis<br />

Among <strong>the</strong> pre-neoplastic lesions found in <strong>the</strong> liver are enzyme-altered foci and dysplastic nodules. After<br />

long-term administration <strong>of</strong> ethanol to rodents, <strong>the</strong>se enzyme-altered foci are observed to contain quiescent<br />

hepatic progenitor cells. In ALD, TNFα and TGFβ1 are markedly up-regulated. TNFα is an important<br />

stimulator <strong>of</strong> oval-cell proliferation: it triggers JNK1 but also activates NFκB, which <strong>the</strong>n activates cellsurvival<br />

machinery. In addition, TGFβ1 is involved in <strong>the</strong> epi<strong>the</strong>lial–mesenchymal transition (EMT), which<br />

plays a role in carcinogenesis.<br />

c.Retinoid depletion<br />

Chronic alcohol consumption decreases vitamin A and retinoid-acid concentrations in <strong>the</strong> liver. In addition,<br />

<strong>the</strong>re is a strong inverse relationship between vitamin A concentration and later development <strong>of</strong> HCC.<br />

The main reason <strong>for</strong> decreased retinoid acid is increased catabolism by ethanol-induced CYP2E1. This<br />

decrease is associated with increased expression <strong>of</strong> <strong>the</strong> AP1 transcriptional complex (JUN and FOS),<br />

resulting in hepatic hyperproliferation and decreased apoptosis, which may contribute to carcinogenesis.<br />

The retinoid pathway has been shown to play an important role in HBV- and HCV-related HCC, and a direct<br />

interaction between viral proteins has been shown. Moreover, it has been proposed that HBx may induce<br />

promoter methylation <strong>of</strong> RAR-beta via up-regulation <strong>of</strong> DNA methyltransferases 1 and 3a.<br />

d.DNA-methylation deficiency<br />

Methylation <strong>of</strong> genes is an important tool in controlling gene expression: hypermethylation induces a<br />

silencing effect and hypomethylation results in increased gene expression. Alcohol consumption interferes<br />

with <strong>the</strong>se methylation processes, mainly by inhibiting S-adenosyl-L-methionine (SAMe) syn<strong>the</strong>sis, which<br />

is <strong>the</strong> universal methyl-group donor and enzyme activator in methyl-transfer reactions.<br />

It has recently been shown that, depending on <strong>the</strong> HCC risk factors (HBV, HCV, or alcohol related), <strong>the</strong><br />

DNA methylation pr<strong>of</strong>ile differs 10 . Moreover, <strong>the</strong> methylation pr<strong>of</strong>ile <strong>of</strong> a set <strong>of</strong> eight genes has been shown<br />

to distinguish <strong>the</strong> clinical features <strong>of</strong> HCC, such as gender, age, HBV-positive tumors, pathological grade,<br />

and alcohol intake when methylation <strong>of</strong> <strong>the</strong> MGMT gene significantly higher.<br />

e. Genotoxicity<br />

Few data on genome-wide HCC analyses show <strong>the</strong> influence <strong>of</strong> etiology on <strong>the</strong> underlying liver disease.<br />

However, as mentioned above, it is possible that alcohol consumption is under-recorded in series that<br />

have a high incidence <strong>of</strong> viral-related HCC. It has been reported that specific deletion <strong>of</strong> <strong>the</strong> 4q34-35<br />

region is associated with heavy alcohol intake, even if <strong>the</strong> patient is infected by HCV. However conflicting<br />

results have been published. Unsupervised global transcriptome analysis <strong>of</strong> HCC did not identify significant<br />

differences between <strong>the</strong> underlying liver pathology. However, direct comparison <strong>of</strong> transcriptome analysis<br />

between HCV and alcohol-related HCC has revealed some differences 11 .<br />

f. O<strong>the</strong>r mechanisms<br />

Alcohol-induced CYP2E1 may interfere with <strong>the</strong> metabolism <strong>of</strong> certain pro-carcinogens, such as<br />

nitrosamines, polycyclic hydrocarbons, and aflatoxins. This interaction increases <strong>the</strong> carcinogenic effect <strong>of</strong><br />

<strong>the</strong>se pro-carcinogens (except <strong>for</strong> nitrosamines simultaneously administered with ethanol).<br />

PROGNOSIS AND TREATMENT OF ALCOHOL-RELATED HCC<br />

None <strong>of</strong> <strong>the</strong> frequently used HCC classification systems take into account <strong>the</strong> etiology <strong>of</strong> liver disease. In<br />

fact, no significant differences have been found in liver function between ALD and viral hepatitis 12 . Moreover,<br />

even though <strong>the</strong> etiology <strong>of</strong> liver disease has been defined as a prognostic factor in some studies, <strong>the</strong><br />

power <strong>of</strong> this finding is small.<br />

A patient’s prognosis depends on access to treatment. Compared to HBV-, HCV-, or NASH-related cirrhosis,<br />

ALD is considered to be self-inflected, and <strong>the</strong> general public and even some pr<strong>of</strong>essionals question <strong>the</strong><br />

degree <strong>of</strong> priority given to <strong>the</strong>se patients. In a study on adherence to AASLD criteria <strong>for</strong> referral <strong>for</strong> liver<br />

transplantation, it has been shown that patients with ALD have a significantly poorer odds ratio <strong>of</strong> receiving

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!